Co-Diagnostics, Inc. Increase (Decrease) in Accounts Receivable
Co-Diagnostics, Inc. (CODX) reported Increase (Decrease) in Accounts Receivable of -$137.76 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-13
- Co-Diagnostics, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was -$33.89K, a 159.26% decline year-over-year.
- Co-Diagnostics, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$103.87K, a 1404.27% decline year-over-year.
- Co-Diagnostics, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $130.84K.
- Co-Diagnostics, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was -$164.19K.
- Co-Diagnostics, Inc. increase (decrease) in accounts receivable for fiscal 2025 was $31.80K.
- Co-Diagnostics, Inc. increase (decrease) in accounts receivable for fiscal 2024 was -$186.39K.
- Co-Diagnostics, Inc. increase (decrease) in accounts receivable for fiscal 2023 was -$2.54M.
- Co-Diagnostics, Inc. increase (decrease) in accounts receivable for fiscal 2022 was -$14.92M, a 270.74% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 3 month as first filed | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 6 month as first filed | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month | Increase (Decrease) in Accounts Receivable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$33.89K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$137.76K 10-Q · filed 2026-08-13 | -$6.92K derived: sum of 3 quarters · filed 2026-08-13 | -$171.11K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | -$103.87K 10-Q · filed 2026-05-14 | $26.97K derived: sum of 2 quarters · filed 2026-05-14 | -$137.22K derived: sum of 3 quarters · filed 2026-05-14 | -$80.04K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $130.84K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$33.35K derived: sum of 2 quarters · filed 2026-03-31 | $23.84K derived: sum of 3 quarters · filed 2026-08-13 | $31.80K 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | -$164.19K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$107.00K derived: sum of 2 quarters · filed 2026-08-13 | -$99.04K 10-Q · filed 2025-11-13 | -$168.01K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $57.19K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $65.15K 10-Q · filed 2026-08-13 | -$3.82K derived: sum of 3 quarters · filed 2026-08-13 | -$327.88K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $7.96K 10-Q · filed 2026-05-14 | -$61.01K derived: sum of 2 quarters · filed 2026-05-14 | -$385.06K derived: sum of 3 quarters · filed 2026-05-14 | -$294.71K derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | -$68.97K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$393.02K derived: sum of 2 quarters · filed 2026-03-31 | -$302.68K derived: sum of 3 quarters · filed 2026-03-31 | -$186.39K 10-K · filed 2026-03-31 | ||||
| 2024-09-30 | -$324.06K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$233.71K derived: sum of 2 quarters · filed 2025-11-13 | -$117.42K 10-Q · filed 2025-11-13 | -$510.57K derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | $90.35K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $206.63K 10-Q · filed 2025-08-14 | -$186.52K derived: sum of 3 quarters · filed 2025-08-14 | -$465.19K derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $116.28K 10-Q · filed 2025-05-08 | -$276.87K derived: sum of 2 quarters · filed 2025-05-08 | -$555.53K derived: sum of 3 quarters · filed 2025-05-08 | -$1.56M derived: sum of 4 quarters · filed 2025-05-08 | ||||
| 2023-12-31 | -$393.15K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$671.82K derived: sum of 2 quarters · filed 2025-03-27 | -$1.67M derived: sum of 3 quarters · filed 2025-03-27 | -$2.54M 10-K · filed 2025-03-27 | ||||
| 2023-09-30 | -$278.67K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$1.28M derived: sum of 2 quarters · filed 2024-11-07 | -$2.14M 10-Q · filed 2024-11-07 | -$2.32M 10-Q · filed 2023-11-09 | -$4.53M derived: sum of 4 quarters · filed 2024-11-07 | |||
| 2023-06-30 | -$999.64K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$1.87M 10-Q · filed 2024-08-08 | -$2.04M 10-Q · filed 2023-08-10 | -$4.25M derived: sum of 3 quarters · filed 2024-08-08 | -$8.22M derived: sum of 4 quarters · filed 2024-08-08 | |||
| 2023-03-31 | -$865.52K 10-Q · filed 2024-05-09 | -$865.66K 10-Q · filed 2023-05-11 | -$3.25M derived: sum of 2 quarters · filed 2024-05-09 | -$7.22M derived: sum of 3 quarters · filed 2024-05-09 | -$16.66M derived: sum of 4 quarters · filed 2024-05-09 | |||
| 2022-12-31 | -$2.38M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | -$6.36M derived: sum of 2 quarters · filed 2024-03-14 | -$15.80M derived: sum of 3 quarters · filed 2024-03-14 | -$14.92M 10-K · filed 2024-03-14 | -$14.96M 10-K · filed 2023-03-16 | |||
| 2022-09-30 | -$3.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$13.41M derived: sum of 2 quarters · filed 2023-11-09 | -$12.54M 10-Q · filed 2023-11-09 | -$6.41M derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | -$9.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$8.57M 10-Q · filed 2023-08-10 | -$2.44M derived: sum of 3 quarters · filed 2023-08-10 | -$593.81K derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | $871.08K 10-Q · filed 2023-05-11 | $7.00M derived: sum of 2 quarters · filed 2023-05-11 | $8.85M derived: sum of 3 quarters · filed 2023-05-11 | $9.55M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $6.13M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $7.97M derived: sum of 2 quarters · filed 2023-03-16 | $8.68M derived: sum of 3 quarters · filed 2023-03-16 | $8.74M 10-K · filed 2023-03-16 | ||||
| 2021-09-30 | $1.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $2.55M derived: sum of 2 quarters · filed 2022-11-10 | $2.61M 10-Q · filed 2022-11-10 | $5.06M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $706.90K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $766.89K 10-Q · filed 2022-08-11 | $3.22M derived: sum of 3 quarters · filed 2022-08-11 | $7.98M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | $59.99K 10-Q · filed 2022-05-12 | $2.51M derived: sum of 2 quarters · filed 2022-05-12 | $7.28M derived: sum of 3 quarters · filed 2022-05-12 | $12.10M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $2.45M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $7.22M derived: sum of 2 quarters · filed 2022-03-24 | $12.04M derived: sum of 3 quarters · filed 2022-03-24 | $12.96M 10-K · filed 2022-03-24 | ||||
| 2020-09-30 | $4.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $9.58M derived: sum of 2 quarters · filed 2021-11-12 | $10.51M 10-Q · filed 2021-11-12 | $10.59M derived: sum of 4 quarters · filed 2021-11-12 | ||||
| 2020-06-30 | $4.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $5.74M 10-Q · filed 2021-08-12 | $5.22M 10-Q · filed 2020-08-13 | $5.82M derived: sum of 3 quarters · filed 2021-08-12 | $5.82M derived: sum of 4 quarters · filed 2021-08-12 | |||
| 2020-03-31 | $924.36K 10-Q · filed 2021-05-13 | $1.01M derived: sum of 2 quarters · filed 2021-05-13 | $1.00M derived: sum of 3 quarters · filed 2021-05-13 | $1.02M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | $82.03K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $79.40K derived: sum of 2 quarters · filed 2021-03-25 | $99.83K derived: sum of 3 quarters · filed 2021-03-25 | $121.46K 10-K · filed 2021-03-25 | ||||
| 2019-09-30 | -$2.63K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2020-11-16 | $17.80K derived: sum of 2 quarters · filed 2020-11-16 | $39.43K 10-Q · filed 2020-11-16 | |||||
| 2019-06-30 | $20.43K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2020-11-03 | $42.06K 10-Q/A · filed 2020-11-03 | ||||||
| 2019-03-31 | $21.64K 10-Q · filed 2020-05-14 | |||||||
| 2018-12-31 | $13.42K 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |